Text Size

Comparison of Two Experimental Mouse Dry Eye Models through Inflammatory Gene Set Enrichment Analysis Based on a Multiplexed Transcriptomic Approach

Kessal K, Daull P, Cimbolini N, Feraille L, Grillo S, Docquier M, Baudouin C, Brignole-Baudouin F, Garrigue JS.

  • 2021
  • International journal of molecular sciences
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Categories

    Preclinical development

  • Affiliations

    INSERM UMR 968, CNRS UMR 7210, Institut de la Vision, IHU ForeSight, Sorbonne Université UM80,75012 Paris, France; Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, INSERM-DGOS CIC1423, IHU FOReSight, 75012 Paris, France; Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Service 3, 75012 Paris, France. SANTEN SAS, Ophthalmic Innovation Center, 91000 Evry-Couronnes, France; Iris Pharma SAS, 06610 La Gaude, France; iGE3 Genomics Platform, Figu Medical School, University of Geneva, CH-1211 Geneva, Switzerland; Ambroise Paré, APHP, Department of Ophthalmology, University Paris Saclay, 92100 Boulogne, France; Faculté de Pharmacie, Université de Paris, 75006 Paris, France.

Related Publications

Burden of Vernal Keratoconjunctivitis in the United States: A Retrospective Claims Database Analysis

Koo E.B.; Yu T.M.; Layton A.J.; Babineaux S.; Fung S.

Review of clinical outcomes of a cationic emulsion tear substitute in patients with dry eye disease

Labetoulle M, Garhöfer G, Ismail D, Garrigue JS, Amrane M, Guillon M, Aragona P, Baudouin C.

Epinastine Cream: A Novel Once-Daily Therapeutic Agent for Allergic Conjunctivitis

Ogura N., Fujisawa K., Kato M.

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022